High Body Mass Index (BMI) in North American Elderly Diffuse Large B-Cell Lymphoma (DLBCL) Patients Treated with Rituximab (R)-CHOP Compensates for Negative Impact of Male Gender

被引：0
|
作者：
Zhou, Zheng [1 ]
Rademaker, Alfred W. [2 ]
Gordon, Leo I. [2 ]
LaCasce, Ann S. [3 ]
Crosby-Thompson, Allison [3 ]
Vanderplas, Ann [4 ]
Abel, Gregory A. [3 ]
Rodriguez, Maria A. [5 ]
Nademanee, Auayporn [6 ]
Kaminski, Mark [7 ]
Czuczman, Myron S. [8 ]
Millenson, Michael M. [9 ]
Niland, Joyce [4 ]
Zelenetz, Andrew D. [10 ]
Friedberg, Jonathan W. [11 ]
Winter, Jane N. [2 ]
机构：
[1] Northwestern Univ, NW Mem Hosp, Feinberg Sch Med, Chicago, IL 60611 USA
[2] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
[3] Dana Farber Canc Inst, Boston, MA 02115 USA
[4] City Hope Natl Med Ctr, Duarte, CA 91010 USA
[5] UT MD Anderson Canc Ctr, Houston, TX USA
[6] City Hope Natl Med Ctr, Duarte, CA USA
[7] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA
[8] Roswell Pk Canc Inst, Buffalo, NY 14263 USA
[9] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA
[10] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[11] Univ Rochester, Med Ctr, Rochester, NY 14642 USA
来源：
BLOOD | 2014年 / 124卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Estimating the impact of rituximab on bcl-2-associated resistance to CHOP using competing risks in elderly patients with diffuse large B-cell lymphoma (DLBCL).
    Mounier, N.
    Briere, J.
    Gisselbrecht, C.
    Lederlin, P.
    Berger, F.
    Bosly, A.
    Tilly, H.
    Reyes, F.
    Gaulard, P.
    Coiffier, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 425S - 425S
  • [22] IMPACT OF RITUXIMAB ON OUTCOMES OF VERY ELDERLY PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA
    Lee, L.
    Khor, S.
    Hoch, J. S.
    Luo, J.
    Bremner, K.
    Krahn, M.
    Crump, M.
    Hodgson, D. C.
    ANNALS OF ONCOLOGY, 2011, 22 : 195 - 195
  • [23] Evaluation of the impact of maintenance rituximab in elderly patients with diffuse large B-cell lymphoma
    不详
    CLINICAL LYMPHOMA & MYELOMA, 2007, 7 (07): : 456 - 457
  • [24] Comparison between R-mini-CHOP and R-Bendamustine in diffuse large B-cell lymphoma (DLBCL) of elderly and comorbid patients
    Hammersen, F. J.
    Ruethrich, M. M.
    Kleber, M.
    Wedding, U.
    Sommer, M.
    Mueller, D.
    Schlattmann, P.
    Hochhaus, A.
    La Rosee, P.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 143 - 144
  • [25] R-split-CHOP chemotherapy for elderly patients with diffuse large B-cell lymphoma
    Kreher, Stephan
    Lammer, Felicitas
    Augustin, Dieter
    Pezzutto, Antonio
    Baldus, Claudia D.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2014, 93 (01) : 70 - 76
  • [26] Prognostic impact of activated B-cell focused classification in diffuse large B-cell lymphoma patients treated with R-CHOP
    Nyman, Heidi
    Jerkeman, Mats
    Karjalainen-Lindsberg, Marja-Liisa
    Banham, Alison H.
    Leppa, Sirpa
    MODERN PATHOLOGY, 2009, 22 (08) : 1094 - 1101
  • [27] Feasibility and preliminary efficacy of R-CHOP-14 in patients with diffuse large B-Cell lymphoma (DLBCL).
    Halaas, JL
    Moskowitz, CH
    Noy, A
    Portlock, C
    Horwitz, S
    Straus, D
    O'Connor, O
    Yahalom, J
    Zelenetz, AD
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 578S - 578S
  • [28] Prognostic significance of international prognostic index (IPI) individual risk factors in patients with diffuse large b cell lymphoma (DLBCL) treated with rituximab (R) and chop (R-CHOP) based chemotherapy
    Akhtar, S.
    Soudy, H.
    Darwish, A.
    Salam, M. Abdel
    Elhassan, T.
    Rehman, A.
    Bakshi, N.
    Maghfoor, I.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S847 - S847
  • [29] Estimating the impact of rituximab on bcl-2-associated resistance to CHOP in elderly patients with diffuse large B-cell lymphoma
    Mounier, Nicolas
    Briere, Josette
    Gisselbrecht, Christian
    Reyes, Felix
    Gaulard, Philippe
    Coiffier, Bertrand
    HAEMATOLOGICA, 2006, 91 (05) : 715 - 716
  • [30] CHOP-rituximab with pegylated liposomal doxorubicin for the treatment of elderly patients with diffuse large B-cell lymphoma
    Zaja, F.
    Tomadini, V.
    Zaccaria, A.
    Lenoci, M.
    Battista, M.
    Molinari, A. L.
    Fabbri, A.
    Battista, R.
    Cabras, M. G.
    Gallamini, A.
    Fanin, R.
    LEUKEMIA & LYMPHOMA, 2006, 47 (10) : 2174 - 2180
12345